Bhaskar Chaudhuri is Director at Arcutis Biotherapeutics, Inc. (ARQT). They have made 18 open-market trades across 3 companies since 2009, most recently 2026-06-12.
CIK 0001458643
11 open-market purchases totalling $507K since 2009, against 7 sales. Across 11 scored buys the stock is up 5.0% at ninety days, and 4.4 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -13.4% | +0.9% | +5.0% |
| Alpha | -8.3% | +0.2% | +4.4% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARQT | SELL | 2021-06-24 | 2021-06-28 | $27.50 | $392K | -1.5% | -10.3% | -13.7% |
| ARQT | SELL | 2021-06-21 | 2021-06-23 | $27.50 | $69K | -7.6% | -11.4% | -17.9% |
| ARQT | SELL | 2021-06-01 | 2021-06-03 | $27.50 | $275K | +6.8% | -4.7% | -20.3% |
| ARQT | SELL | 2021-04-20 | 2021-05-19 | $28.03 | $525K | +12.9% | +12.6% | -19.3% |
| ARQT | SELL | 2021-03-22 | 2021-03-24 | $31.10 | $622K | -1.6% | +2.3% | -6.7% |
| ARQT | SELL | 2021-02-22 | 2021-02-24 | $35.52 | $710K | -13.5% | -19.6% | -28.2% |
| ARQT | SELL | 2021-01-29 | 2021-02-02 | $33.24 | $663K | -2.2% | -14.4% | -3.1% |
| TLGT | BUY | 2019-06-03 | 2019-06-04 | $0.70 | $7K | -19.2% | +5.9% | +50.0% |
| VRX | BUY | 2009-11-20 | 2009-11-23 | $33.31 | $100K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-11-18 | 2009-11-19 | $33.58 | $80K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-11-10 | 2009-11-12 | $32.81 | $50K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-08-14 | 2009-08-17 | $26.69 | $90K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-05-26 | 2009-05-26 | $22.19 | $30K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-05-18 | 2009-05-18 | $22.06 | $30K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-05-11 | 2009-05-12 | $19.50 | $30K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-05-04 | 2009-05-04 | $17.05 | $30K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-04-27 | 2009-04-27 | $17.32 | $30K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-04-20 | 2009-04-21 | $17.62 | $30K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.